[1] |
中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521. |
[2] |
闫坤涛, 刘寅, 高静. 肠道微生态与心血管疾病相关性的研究进展[J]. 中华心血管病杂志, 2018, 46(2): 165. doi: 10.3760/cma.j.issn.0253-3758.2018.02.018 |
[3] |
LEVER M, GEORGE PM, SLOW S, et al. Betaine and trimethylamine-N-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: an observational study[J]. PLoS One, 2014, 9(12): e114969. doi: 10.1371/journal.pone.0114969 |
[4] |
SENTHONG V, WANG Z, LI X S, et al. Intestinal microbiota-generated metabolite trimethylamine-N-oxide and 5-year mortality risk in stable coronary artery disease: the contributory role of intestinal microbiota in a COURAGE-like patient cohort[J]. J Am Heart Assoc, 2016, 5(6): e002816. doi: 10.1161/JAHA.115.002816 |
[5] |
LI XS, OBEID S, KLINGENBERG R, et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors[J]. Eur Heart J, 2017, 38(11): 814. |
[6] |
SUZUKI T, HEANEY LM, JONES DJ, et al. Trimethylamine N-oxide and risk stratification after acute myocardial infarction[J]. Clin Chem, 2017, 63(1): 420. doi: 10.1373/clinchem.2016.264853 |
[7] |
WANG P, QIANG H, SONG Y, et al. Association between nonalcoholic fatty liver and gensini score in patients with coronary heart disease: a cross-sectional study[J]. Cardiology, 2019, 144(3/4): 90. |
[8] |
JUAREZ-OROZCO LE, SARASTE A, CAPODANNO D, et al. Impact of a decreasing pre-test probability on the performance of diagnostic tests for coronary artery disease[J]. Eur Heart J Cardiovasc Imaging, 2019, 20(11): 1198. doi: 10.1093/ehjci/jez054 |
[9] |
沈迎, 张瑞岩, 沈卫峰. 稳定性冠心病血运重建策略进展——2018中国稳定性冠心病诊断与治疗指南解读[J]. 心脑血管病防治, 2019, 19(2): 107. doi: 10.3969/j.issn.1009-816x.2019.02.001 |
[10] |
张新超, 于学忠, 陈凤英, 等. 急性冠脉综合征急诊快速诊治指南(2019)[J]. 中国急救医学, 2019, 39(4): 301. doi: 10.3969/j.issn.1002-1949.2019.04.001 |
[11] |
AL-WAIZ M, MIKOV M, MITCHELL S C, et al. The exogenous origin of trimethylamine in the mouse[J]. Metabolism, 1992, 41(2): 135. doi: 10.1016/0026-0495(92)90140-6 |
[12] |
LANG DH, YEUNG CK, PETER RM, et al. Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3[J]. Biochem Pharmacol, 1998, 56(8): 1005. doi: 10.1016/S0006-2952(98)00218-4 |
[13] |
莫乔莹, 鲁星琴, 姚亚丽. 老年冠心病患者出现心律失常临床相关因素的研究进展[J]. 老年医学与保健, 2020, 26(1): 159. doi: 10.3969/j.issn.1008-8296.2020.01.042 |
[14] |
TAN Y, SHENG Z, ZHOU P, et al. Plasma trimethylamine N-oxide as a novel biomarker for plaque rupture in patients with ST-segment-elevation myocardial infarction[J]. Circ Cardiovasc Interv, 2019, 12(1): e007281. doi: 10.1161/CIRCINTERVENTIONS.118.007281 |
[15] |
BOGIATZI C, GLOOR G, ALLEN-VERCOE E, et al. Metabolic products of the intestinal microbiome and extremes of atherosclerosis[J]. Atherosclerosis, 2018, 273: 91. doi: 10.1016/j.atherosclerosis.2018.04.015 |
[16] |
KOREN O, SPOR A, FELIN J, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis[J]. Proc Natl Acad Sci U S A, 2011, 108(Suppl 1): 4592. |
[17] |
SANDEK A, BAUDITZ J, SWIDSINSKI A, et al. Altered intestinal function in patients with chronic heart failure[J]. J Am Coll Cardiol, 2007, 50(16): 1561. doi: 10.1016/j.jacc.2007.07.016 |
[18] |
SANTISTEBAN MM, QI Y, ZUBCEVIC J, et al. Hypertension-Linked Pathophysiological Alterations in the Gut[J]. Circ Res, 2017, 120(2): 312. doi: 10.1161/CIRCRESAHA.116.309006 |
[19] |
张亚男, 于雪. 血浆氧化三甲胺水平对冠心病患者预后的预测作用: 剂量-反应Meta分析[J]. 中国循环杂志, 2021, 36(2): 149. doi: 10.3969/j.issn.1000-3614.2021.02.007 |
[20] |
WANG Z, ZHAO Y. Gut microbiota derived metabolites in cardiovascular health and disease[J]. Protein Cell, 2018, 9(5): 416. doi: 10.1007/s13238-018-0549-0 |
[21] |
秦光耀, 陈吉, 陈维. 早期强化阿托伐他汀对冠心病病人炎症因子的影响[J]. 中西医结合心脑血管病杂志, 2019, 17(12): 1841. doi: 10.12102/j.issn.1672-1349.2019.12.021 |